Neuroendocrine Tumours Group

COSA has developed consensus guidelines for the management of neuroendocrine neoplasms (NENs). These guidelines aim to raise awareness of the increasing multidisciplinary management options, including supportive care, which may be appropriate for patients with this uncommon group of diseases.

The CNSA Vascular Access Devices: Evidence-Based Clinical Practice Guidelines, 2024 provide recommendations for clinical practice based on current evidence. This knowledge base, alongside your clinical expertise, individual patient preferences, products and their appropriate application, and finally within your local workplace or environment can be integrated together into comprehensive approach to vascular access management for the individual cancer patient.